Tafinlar 50 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DR26F9AH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,581
Award facts
- Contract value 100% obligated
- $14,581.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract with a ceiling value of $14,581.28. This non-set-aside award is to be completed by November 28, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply medications, medical supplies, and healthcare commodities to military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare procurement through the Defense Logistics Agency. The company's extensive portfolio of competitively awarded federal contracts demonstrates capability across multiple therapeutic domains, including oncology treatments like Tafinlar, as well as diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The firm's status as a prime vendor under the DLA Troop Support Medical contract underscores its role in supporting the Defense Health Agency and broader federal healthcare operations through flexible, comprehensive pharmaceutical supply arrangements.
Quick answers
Who was awarded contract SPE2DR26F9AH3?
SPE2DR26F9AH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F9AH3 worth?
The government has obligated $14,581 on SPE2DR26F9AH3.
Is contract SPE2DR26F9AH3 an order under another contract?
Yes. SPE2DR26F9AH3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AH3 competed?
The extent of competition for SPE2DR26F9AH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award